Estimated Theoretical Benefit of Aggressive LDL Lowering in Patients With Symptomatic Intracranial Atherosclerosis.
Siegler JE, Badillo Goicoechea E, Yaghi S, Morsi RZ, Arevalo A, Smith MM, Kothari S, Desai H, Sehgal N, Rana R, Kellogg CA, Jhaveri A, de Havenon A, Dunne T, Cameron K, Chaturvedi S, Ghannam M, Prabhakaran S, Coleman E, Brorson JR, Mehendale R, Kass-Hout T.
Siegler JE, et al. Among authors: dunne t.
Neurology. 2025 Jul 8;105(1):e213768. doi: 10.1212/WNL.0000000000213768. Epub 2025 May 30.
Neurology. 2025.
PMID: 40446174
Clinical Trial.